BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33634421)

  • 1. Mortality and Survival Among Octogenarians with Localized Pancreatic Head Cancer: a National Cancer Database Analysis.
    Hue JJ; Bingmer K; Sugumar K; Ocuin LM; Rothermel LD; Winter JM; Ammori JB; Hardacre JM
    J Gastrointest Surg; 2021 Oct; 25(10):2582-2592. PubMed ID: 33634421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical quality data and survival after pancreatic cancer resections: a comparison of results for octogenarians and younger patients.
    Gangl O; Fröschl U; Függer R
    Wien Klin Wochenschr; 2014 Dec; 126(23-24):757-61. PubMed ID: 25249303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
    Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.
    Datta J; Willobee BA; Ryon EL; Shah MM; Drebin JA; Kooby DA; Merchant NB
    JAMA Surg; 2021 May; 156(5):489-495. PubMed ID: 33533898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis.
    Jeong H; Lim SY; Jeon HJ; Yoon SJ; Kim H; Han IW; Heo JS; Shin SH
    ANZ J Surg; 2023 Nov; 93(11):2655-2663. PubMed ID: 37658597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study.
    Bergquist JR; Puig CA; Shubert CR; Groeschl RT; Habermann EB; Kendrick ML; Nagorney DM; Smoot RL; Farnell MB; Truty MJ
    J Am Coll Surg; 2016 Jul; 223(1):52-65. PubMed ID: 27049786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
    Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
    J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of chemotherapy sequencing on resectable pancreatic cancer by stage.
    Vega EA; Kutlu OC; Salehi O; Alarcon SV; Abudalou M; Kozyreva O; Krishnan S; Lee D; Freeman R; Conrad C
    Surg Oncol; 2022 Mar; 40():101694. PubMed ID: 34973593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma.
    Xiong J; Wei A; Ke N; He D; Chian SK; Wei Y; Hu W; Liu X
    Int J Surg; 2017 Dec; 48():134-141. PubMed ID: 29081373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
    Labori KJ; Bratlie SO; Andersson B; Angelsen JH; Biörserud C; Björnsson B; Bringeland EA; Elander N; Garresori H; Grønbech JE; Haux J; Hemmingsson O; Liljefors MG; Myklebust TÅ; Nymo LS; Peltola K; Pfeiffer P; Sallinen V; Sandström P; Sparrelid E; Stenvold H; Søreide K; Tingstedt B; Verbeke C; Öhlund D; Klint L; Dueland S; Lassen K;
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):205-217. PubMed ID: 38237621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer.
    Shin SH; Park Y; Hwang DW; Song KB; Lee JH; Kwon J; Yoo C; Alshammary S; Kim SC
    Anticancer Res; 2019 Feb; 39(2):1005-1012. PubMed ID: 30711988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan.
    Satoi S; Murakami Y; Motoi F; Sho M; Matsumoto I; Uemura K; Kawai M; Kurata M; Yanagimoto H; Yamamoto T; Mizuma M; Unno M; Kinoshita S; Akahori T; Shinzeki M; Fukumoto T; Hashimoto Y; Hirono S; Yamaue H; Honda G; Kwon M
    Pancreas; 2016 Aug; 45(7):1003-9. PubMed ID: 26692442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.
    Renz BW; Khalil PN; Mikhailov M; Graf S; Schiergens TS; Niess H; Boeck S; Heinemann V; Hartwig W; Werner J; Bruns CJ; Kleespies A
    Int J Surg; 2016 Apr; 28():118-25. PubMed ID: 26906329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of adenocarcinoma of the pancreatic tail in the elderly.
    Boutros CS; Hue JJ; Elshami M; Rothermel LD; Hoehn RS; Ammori JB; Winter JM; Ocuin LM; Hardacre JM
    J Surg Oncol; 2023 Mar; 127(3):405-412. PubMed ID: 36301227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of pancreaticoduodenectomy in octogenarians: Single institution's experience and review of the literature.
    Beltrame V; Gruppo M; Pastorelli D; Pedrazzoli S; Merigliano S; Sperti C
    J Visc Surg; 2015 Nov; 152(5):279-84. PubMed ID: 26117303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the significance of adjuvant chemotherapy in patients with stage ⅠA pancreatic ductal adenocarcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Matsunaga Y; Shiihara M; Yamamoto M
    Pancreatology; 2021 Apr; 21(3):581-588. PubMed ID: 33579600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcomes after pancreatoduodenectomy for pancreatic ductal adenocarcinoma in octogenarians: case-control study.
    Pande R; Attard JA; Al-Sarireh B; Bhogal RH; Farrugia A; Fusai G; Harper S; Hidalgo-Salinas C; Jah A; Marangoni G; Mortimer M; Pizanias M; Prachialias A; Roberts KJ; Hee CS; Soggiu F; Srinivasan P; Chatzizacharias NA
    BJS Open; 2023 Jul; 7(4):. PubMed ID: 37432365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution.
    Stauffer JA; Coppola A; Villacreses D; Mody K; Johnson E; Li Z; Asbun HJ
    Surg Endosc; 2017 May; 31(5):2233-2241. PubMed ID: 27604369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.